Clinical trial
Intra-Articular Injection of Botulinum Toxin Type A for Shoulder Pain
NCT00211718 · Minneapolis Veterans Affairs Medical Center, U.S. Fed · Unknown status
Key facts
| NCT number | NCT00211718 |
|---|---|
| Title | Intra-Articular Injection of Botulinum Toxin Type A for Shoulder Pain |
| Official title | Intra-Articular Injection of Botulinum Toxin Type A for the Treatment of Shoulder Pain: A Randomized, Double Blinded, Placebo Controlled Trial |
| Lead sponsor | Minneapolis Veterans Affairs Medical Center, U.S. Fed |
| Collaborators | Allergan Industry Center for Veterans Research and Education |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Arthritis, Shoulder Pain |
| Intervention type | Drug |
| Interventions | intra-articular botulinum toxin type a |
| Enrollment | 40 |
| Start date | Jul 1, 2004 |
| Completion | Jun 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Nov 3, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: